Based on the Mind Medicine Inc stock forecast from 5 analysts, the average analyst target price for Mind Medicine Inc is USD 24.50 over the next 12 months. Mind Medicine Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Mind Medicine Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Mind Medicine Inc’s stock price was USD 8.39. Mind Medicine Inc’s stock price has changed by +11.57% over the past week, +44.41% over the past month and +220.23% over the last year.
No recent analyst target price found for Mind Medicine Inc
No recent average analyst rating found for Mind Medicine Inc
Company Overview Mind Medicine Inc
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York. Read Less
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyp...Read More
Frequently Asked Questions About Mind Medicine Inc (MNMD) Stock
Based on ratings from 5 analysts Mind Medicine Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 5 buy, sell and hold ratings.
Unfortunately we do not have enough data on MNMD's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for MNMD is USD 24.50 over the next 12 months. The maximum analyst target price is USD 35 while the minimum anlayst target price is USD 14.
Unfortunately we do not have enough data on MNMD's stock to indicate if its overvalued.
The last closing price of MNMD's stock was USD 8.39.
The most recent market capitalization for MNMD is USD 0.46B.
Based on targets from 5 analysts, the average taret price for MNMD is projected at USD 24.50 over the next 12 months.
This means that MNMD's stock price may go up by +192.01% over the next 12 months.
We can't find any ETFs which contains Mind Medicine Inc's stock.
As per our most recent records Mind Medicine Inc has 57 Employees.
Mind Medicine Inc's registered address is One World Trade Center, New York, NY, United States, 10007.
You can get more information about it from Mind Medicine Inc's website at https://www.mindmed.co.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Mind Medicine Inc (MNMD) Stock
Based on ratings from 5 analysts Mind Medicine Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 5 buy, sell and hold ratings.
Unfortunately we do not have enough data on MNMD's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for MNMD is USD 24.50 over the next 12 months. The maximum analyst target price is USD 35 while the minimum anlayst target price is USD 14.
Unfortunately we do not have enough data on MNMD's stock to indicate if its overvalued.
The last closing price of MNMD's stock was USD 8.39.
The most recent market capitalization for MNMD is USD 0.46B.
Based on targets from 5 analysts, the average taret price for MNMD is projected at USD 24.50 over the next 12 months.
This means that MNMD's stock price may go up by +192.01% over the next 12 months.
We can't find any ETFs which contains Mind Medicine Inc's stock.
As per our most recent records Mind Medicine Inc has 57 Employees.
Mind Medicine Inc's registered address is One World Trade Center, New York, NY, United States, 10007.
You can get more information about it from Mind Medicine Inc's website at https://www.mindmed.co.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MNMD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
